1. Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection. (October 2016) Authors: Kaleko, Michael; Bristol, J. Andrew; Hubert, Steven; Parsley, Todd; Widmer, Giovanni; Tzipori, Saul; Subramanian, Poorani; Hasan, Nur; Koski, Perrti; Kokai-Kun, John; Sliman, Joseph; Jones, Annie; Connelly, Sheila Journal: Anaerobe Issue: Volume 41(2016) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Passive Immunization with Anti-Pertussis Toxin Humanized Monoclonal Antibody Mitigates Clinical Signs of Pertussis Infection in Newborn Baboons. (4th October 2017) Authors: Maynard, Jennifer; Nguyen, Annalee; Wolf, Roman; Papin, James; Connelly, Sheila; Kaleko, Michael Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SYN-006, a Novel Carbapenemase, Intended to Protect the Gut Microbiome from Antibiotic-Mediated Damage May Also Reduce Propagation of Carbapenem-Resistant Pathogens. (4th October 2017) Authors: Kaleko, Michael; Furlan-Freguia, Christian; Subramanian, Poorani; Hasan, Nur A; Colwell, Rita R; Connelly, Sheila Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gut Antibiotic Inactivation by Β-Lactamases Is Intended to Prevent Microbiome Damage and Attenuate Antibiotic Resistance in Large Animal Models. (4th October 2017) Authors: Connelly, Sheila; Furlan-Freguia, Christian; Subramanian, Poorani; Hasan, Nur A; Colwell, Rita R; Kaleko, Michael Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 270SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora. (December 2014) Authors: Kaleko, Michael; Bristol, Andrew; Connelly, Sheila; Koski, Pertti Journal: Open forum infectious diseases Issue: Volume 1(2014)Supplement 1 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis. (26th November 2018) Authors: Connelly, Sheila; Furlan-Freguia, Christian; Fanelli, Brian; Hasan, Nur A; Colwell, Rita R; Kaleko, Michael Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome. (October 2018) Authors: Connelly, Sheila; Subramanian, Poorani; Hasan, Nur A.; Colwell, Rita R.; Kaleko, Michael Journal: Anaerobe Issue: Volume 53(2018) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗